Ishihara Chemical Co., Ltd. (TYO:4462)
2,635.00
-37.00 (-1.38%)
Jun 4, 2026, 11:29 AM JST
Ishihara Chemical Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 9,168 | 6,531 | 6,440 | 5,927 | 5,535 |
Short-Term Investments | 3,375 | 1,390 | 100 | - | - |
Cash & Short-Term Investments | 12,543 | 7,921 | 6,540 | 5,927 | 5,535 |
Cash Growth | 58.35% | 21.12% | 10.34% | 7.08% | 4.04% |
Accounts Receivable | 5,506 | 5,514 | 5,653 | 5,080 | 4,535 |
Receivables | 5,506 | 5,514 | 5,653 | 5,080 | 4,535 |
Inventory | 2,388 | 2,169 | 2,452 | 2,411 | 1,721 |
Other Current Assets | 179 | 228 | 99 | 185 | 90 |
Total Current Assets | 20,616 | 15,832 | 14,744 | 13,603 | 11,881 |
Property, Plant & Equipment | 5,764 | 5,662 | 5,784 | 5,499 | 5,569 |
Long-Term Investments | 3,392 | 5,220 | 7,337 | 7,331 | 8,351 |
Other Intangible Assets | 235 | 282 | 51 | 70 | 81 |
Other Long-Term Assets | 2 | 1 | 1 | 2 | 2 |
Total Assets | 30,009 | 26,997 | 27,917 | 26,505 | 25,884 |
Accounts Payable | 2,730 | 2,828 | 2,756 | 2,859 | 2,559 |
Accrued Expenses | 275 | 284 | 265 | 241 | 255 |
Current Income Taxes Payable | 738 | 629 | 405 | 387 | 426 |
Other Current Liabilities | 488 | 623 | 655 | 438 | 473 |
Total Current Liabilities | 4,231 | 4,364 | 4,081 | 3,925 | 3,713 |
Pension & Post-Retirement Benefits | 57 | 53 | 47 | 50 | 51 |
Long-Term Deferred Tax Liabilities | 679 | 483 | 497 | 437 | 476 |
Other Long-Term Liabilities | 317 | 199 | 186 | 194 | 151 |
Total Liabilities | 5,284 | 5,099 | 4,811 | 4,606 | 4,391 |
Common Stock | 1,980 | 1,980 | 1,980 | 1,980 | 1,980 |
Additional Paid-In Capital | 2,259 | 2,254 | 2,254 | 2,294 | 2,293 |
Retained Earnings | 21,619 | 19,223 | 19,280 | 18,356 | 17,150 |
Treasury Stock | -2,293 | -2,305 | -1,191 | -1,362 | -683 |
Comprehensive Income & Other | 1,160 | 746 | 783 | 631 | 753 |
Shareholders' Equity | 24,725 | 21,898 | 23,106 | 21,899 | 21,493 |
Total Liabilities & Equity | 30,009 | 26,997 | 27,917 | 26,505 | 25,884 |
Net Cash (Debt) | 12,543 | 7,921 | 6,540 | 5,927 | 5,535 |
Net Cash Growth | 58.35% | 21.12% | 10.34% | 7.08% | 4.43% |
Net Cash Per Share | 918.03 | 557.27 | 437.49 | 388.12 | 351.07 |
Filing Date Shares Outstanding | 13.67 | 13.66 | 14.86 | 14.96 | 15.24 |
Total Common Shares Outstanding | 13.67 | 13.66 | 14.93 | 15.13 | 15.67 |
Working Capital | 16,385 | 11,468 | 10,663 | 9,678 | 8,168 |
Book Value Per Share | 1809.29 | 1603.37 | 1547.99 | 1447.05 | 1371.92 |
Tangible Book Value | 24,490 | 21,616 | 23,055 | 21,829 | 21,412 |
Tangible Book Value Per Share | 1792.09 | 1582.72 | 1544.58 | 1442.42 | 1366.75 |